Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
AQW-051 is a partial agonist of the α7 nicotinic acetylcholine receptor (nAChR).1 It induces calcium influx in GH3 cells expressing α7 nAChR (EC50 = 38.9 nM). AQW-051 (0.03 or 0.3 mg/kg) improves learning and memory in the social recognition test in mice. It improves learning and memory in the Morris water maze test in rats when administered at a dose of 3 mg/kg. AQW-051 (2, 8, or 15 mg/kg per day) increases the duration of response to L-DOPA-induced increases in coordination in an ovariectomized cynomolgus monkey model of MPTP-induced Parkinson's disease.2
WARNING This product is not for human or veterinary use.
1. AQW051, a novel, potent and selective α7 nicotinic ACh receptor partial agonist: Pharmacological characterization and phase I evaluation. Br. J. Pharmacol. 172(5), (2015).
2. AQW051, a novel and selective nicotinic acetylcholine receptor α7 partial agonist, reduces ʟ-